Lian Liu

机构：Shandong University, Ministry of Education, Qilu Hospital of Shandong University · ORCID：0000-0001-5868-4482

发表论文 332 篇 · 总被引 8418 次 · h-index 47

代表论文

• First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial (2025 · Nature Medicine · 被引 89)
• An Eye-Tracking Study on Exploring Children’s Visual Attention to Streetscape Elements (2025 · Buildings · 被引 18)
• N 6 ‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis (2025 · 癌症：英文版 · 被引 16)
• First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 10)
• Disitamab vedotin (RC48), tislelizumab, and S-1 as first-line therapy for HER2-overexpressing advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Updated results from the RCTS trial. (2025 · Journal of Clinical Oncology · 被引 8)
• Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer (2025 · British Journal of Cancer · 被引 8)